FDA Adverse Event Injury Summary report: N

PELVISOFT ACELLULAR COLLAGEN BIOMESH

MDR report key: 2841973 · Received November 14, 2012

Report

Report Number
1018233-2012-01725
Event Type
Injury
Date Received
November 14, 2012
Report Date
January 12, 2017
Manufacturer
TISSUE SCIENCE LABORATORIES
Product Code
FTM
PMA / PMN Number
K031332
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE REMAINS IMPLANTED. THE FINISHED PRODUCT MET ALL SPECS PRIOR TO BEING RELEASED FOR GENERAL DISTRIBUTION. THE INSTRUCTIONS FOR USE, WHICH ACCOMPANIES ALL DEVICES, CURRENTLY ADDRESSES POTENTIAL RISKS ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE PRECAUTIONS: PELVISOFT BIOMESH IS FOR SINGLE-PATIENT USE ONLY AND IS TO BE IMPLANTED SURGICALLY. IF EITHER THE OUTER POLYESTER/POLYETHYLENE POUCH OR THE INNER FOIL POUCH HAS BEEN PERFORATED OR TORN IN SHIPMENT OR STORAGE, THEN THE ENCLOSED PELVISOFT BIOMESH SHOULD NOT BE USED. PELVISOFT BIOMESH SHOULD BE HYDRATED OR MOIST WHEN THE PACKAGE IS OPENED. DEHYDRATED OR DRY TISSUE SHOULD NOT BE IMPLANTED. (B)(4).

Additional Manufacturer Narrative · 1

THE INFORMATION PROVIDED BY BARD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BARD.

Description of Event or Problem · 1

THE REPORTED EVENT IS ASSOCIATED WITH MDR #'S 1018233-2012-01726, 01727 AND 01728. THERE HAVE BEEN NO ALLEGATION OF DEFICIENCY OR SERIOUS INJURY AGAINST THIS PRODUCT. THIS MDR IS BEING FILED IN ASSOCIATION WITH THE ALLEGED EVENT FILED BY THE PT'S ATTORNEY ON MDR #'S 1018233-2012-01726, 01727, AND 01728.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PELVISOFT ACELLULAR COLLAGEN BIOMESH FTM TISSUE SCIENCE LABORATORIES NA UNK

Patients

Seq Age Sex Outcome Treatment
1 46 YR Required Intervention ALIGN S URETHRAL SUPPORT SYSTEM| AVAULTA POSTERIOR BIOSYNTHETIC SUPPORT SYSTEM